1.0Site da Brakke Consultinghttps://brakkeconsulting.com/ptNews from Brakke Consultingrich600338<blockquote class="wp-embedded-content" data-secret="Lo9jfFqnHG"><a href="https://brakkeconsulting.com/pt/22112/">Notícias e notas de saúde animal de 18 de outubro de 2002</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/22112/embed/#?secret=Lo9jfFqnHG" width="600" height="338" title="“Animal Health News & Notes for October 18, 2002” — Brakke Consulting Website" data-secret="Lo9jfFqnHG" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>****************************************************************** Brakke Consulting’s Animal Health News & Notes for October 18, 2002 Copyright © Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES > Pfizer reported that animal health sales in the third quarter 2002 increased 10% to $280 million, compared to the same period in 2001. This solid performance was led by the strong growth of companion animal products Revolution, Rimadyl, and Clavamox/Synulox and of the livestock medicine RespiSure/Stellamune. (company website) > Novartis reported that animal health sales for the third quarter 2002 were CHF 234 million ($148 million), an increase of 4% over the third quarter 2001. The first nine months of 2002 increased 4% (12% in local currencies) to CHF 746 million ($473 million). US sales grew strongly, supported by acquired vaccine businesses, which contributed 5 percentage points to the business unit’s sales growth. The worldwide companion animal segment was driven by strong sales of Interceptor, Sentinel and Fortekor. A number of new products were launched in key markets, and the farm animal segment benefited from the recovery of the UK foot and mouth epidemic. (company press release) > Colgate-Palmolive reported results for the third quarter 2002. Hill’s Pet Nutrition (13% of Company Sales), reported strong results both domestically and internationally that contributed to 6.5% unit volume growth in the third quarter. Dollar sales rose 8.0% versus third quarterView Full Post;